A second main finding is the confirmation of aberrant B-cell activation in MS, where CD80+B-cells and plasmablasts are increased in the CSF and correlate with intrathecal immunoglobulin G production [47], [48]. This evidence concerns the gene CD80 and myeloid sarcoma.